Roche Announces Positive Phase I Results Of CT-996 For Obesity Treatment
17/7 07:27
(RTTNews) - Roche (RHHBY) announced positive results from two arms of an ongoing multi-part Phase I clinical trial for CT-996, an investigational, once-daily, oral small molecule GLP-1 receptor agonist being developed for the treatment of both type 2 diabetes and obesity....